Intestinal CYP3A5 genotype and MDR1 expression influence apparent clearance of tacrolimus in adult living-donor liver transplant recipients

被引：0
|
作者：
Fukudo, Masahide
Yoshimura, Atsushi
Yano, Ikuko
Masuda, Satohiro
Uesugi, Miwa
Hosohata, Keiko
Katsura, Toshiya
Takada, Yasutsugu
Uemoto, Shinji
Inui, Ken-ichi
机构：
[1] Kyoto Univ Hosp, Dept Pharm, Kyoto 606, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Transplantat & Immunol, Kyoto, Japan
来源：
THERAPEUTIC DRUG MONITORING | 2007年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
73
引用
下载
收藏
页码：484 / 484
页数：1
相关论文
共 50 条
  • [11] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [12] Impact of CYP3A5 and MDR1 polymorphisms on tacrolimus and sirolimus kinetics of kidney transplant recipients
    Frisman, M
    Renders, L
    Haenisch, S
    Mosyagin, I
    Cascorbi, I
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 705 - 706
  • [13] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [14] Influence on MDR1 and CYP3A5 Polymorphisms on the Pharmacokinetic of Once Daily Formulation of Tacrolimus in Liver Transplant Patients
    Bramuglia, G. F.
    Cairo, F.
    Buendia, J.
    De Davila, M.
    Schaiquevich, P.
    Otamendi, E.
    Powarzniak, Y.
    Nafissi, J.
    Ruf, A.
    Villamil, F.
    TRANSPLANTATION, 2012, 94 (10) : 1184 - 1184
  • [15] Effect of MDR1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype
    Vanhove, Thomas
    Annaert, Pieter
    Kuypers, Dirk R. J.
    TRANSPLANTATION, 2016, 100 (07) : S167 - S168
  • [16] Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
    Li, D.
    Lu, W.
    Zhu, J.-Y.
    Gao, J.
    Lou, Y.-Q.
    Zhang, G.-L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 505 - 515
  • [17] Clinical Relevance and Prevalence of Polymorphisms in CYP3A5 and MDR1 Genes That Encode Tacrolimus Biotransformation Enzymes in Liver Transplant Recipients
    Barrera-Pulido, L.
    Aguilera-Garcia, I.
    Docobo-Perez, F.
    Alamo-Martinez, J. M.
    Pareja-Ciuro, F.
    Nunez-Roldan, A.
    Gomez-Bravo, M. A.
    Bernardos-Rodriguez, A.
    TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) : 2949 - 2951
  • [18] EFFECTS OF RECIPIENTS' MDR1 AND CYP3A5 GENOTYPES ON TACROLIMUS DOSE REQUIREMENTS AFTER LIVER TRANSPLANTATION
    Maschmeier, M.
    Cicinnati, V. R.
    Iacob, S.
    Radtke, A.
    Schomacher, T.
    Kabar, I.
    Huesing, A.
    Wilms, C.
    Schmidt, H. H.
    Beckebaum, S.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 29 - 29
  • [19] IMPACT OF MDR1 AND CYP3A5 GENETIC POLYMORPHISMS ON TACROLIMUS DOSAGE REQUERIMENTS AND ACUTE REJECTION IN CAUCASIAN LIVER TRANSPLANT RECIPIENTS
    Mo Alamo, Jose
    Gomez-Bravo, Miguel A.
    Brunet, Merce
    Salcedo, Magdalena
    Fondevilla, Constantino
    Suarez, Francisco
    Castellote, Jose
    Rufian, Sebastian
    Pons, Jose A.
    Bilbao, Itxarone
    Torrademe, Elisabet
    Barrera, Lydia
    TRANSPLANT INTERNATIONAL, 2011, 24 : 247 - 247
  • [20] Impact of MDR1 and CYP3A5 Genetic Polymorphisms on Tacrolimus Dosage Requirements and Acute Rejection in Caucasian Liver Transplant Recipients
    Serra, M. Brunet
    Bravo, M. A. Gomez
    Salcedo, M.
    Suarez, F.
    Castellote, J.
    Rufian, S.
    Pons, J. A.
    Bilbao, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 186 - 186
12345